Summary
Only one peptide of CD4 (amino acid residues 70–132) among 16 synthetic peptide fragments selectively inhibited HIV-1 replication and HIV-1-induced syncytium formation. Several smaller peptides within this region did not show any activity, except for the peptide (86–132) which showed somewhat lower activity.
References
Atherton E, Sheppard RC (1985) Solid phase peptide synthesis using N-fluorenylmethoxycarbonyl amino acid pentafluorophenyl esters. J Chem Soc Chem Commun 1985: 165–166
Berger EA, Fuerst TR, Moss B (1988) A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus. Proc Natl Acad Sci USA 85: 2357–2361
Biddison W, Rao PE, Thalle MA, Goldstein G, Shaw S (1982) Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T-lymphocytes specific for SB antigens. J Exp Med 156: 1065–1076
Carpino LA, Han GY (1970) The 9-fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting group. J Am Chem Soc 92: 5748–5749
Classon BJ, Tsagaratos J, McKenzie IFC, Walker ID (1986) Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bond. Proc Natl Acad Sci USA 83: 4499–4503
Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767
Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW (1988) A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331: 82–84
Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT, Flavell RA (1988) HIV infection is blocked in vitro by recombinant soluble CD4. Nature 331: 76–78
Fujii N, Otaka A, Sugiyama N, Hatano M, Yajima H (1987) Evaluation of trimethylsilyl bromide as a hard-acid deprotecting reagent in peptide synthesis. Chem Pharm Bull (Tokyo) 35: 3880–3883
Gay D, Maddon P, Sekaly R, Talle MA, Godfrey M, Long E, Goldstein G, Chess L, Axel R, Kappler J, Marrack P (1987) Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 328: 626–629
Hussey RE, Richardson NE, Kowalski M, Brown NR, Chang H-C, Siliciano RF, Dorfman T, Walker B, Sodroski J, Reinherz EL (1988) A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature 331: 78–81
Ikuta K, Morita C, Nakai M, Yamamoto N, Kato S (1988) Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV. Jpn J Cancer Res (Gann) 79: 418–423
Ikuta K, Imai H, Ueda S, Suehiro S, Yamamoto N, Kato S (1987) Amplification of human immunodeficiency virus production from a virus-producing cell line in culture at high cell density. Jpn J Cancer ReS (Gann) 78: 643–647
Jameson BA, Rao PE, Kong LI, Hahn BH, Shaw GM, Hood LE, Kent SBH (1988) Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science 240: 1335–1339
Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J-C, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767–768
Lifson JD, Hwang KM, Nara PL, Fraser B, Padgett M, Dunlop NM, Eiden LE (1988) Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science 241: 712–716
Maddon PJ, Littman DR, Godfrey M, Maddon DE, Chess L, Axel R (1985) The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42: 93–104
Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47: 333–348
McDougal JS, Nicholson JKA, Cross GD, Cort SP, Kennedy MS, Mawle AC (1986) Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol 137: 2937–2944
McDougal JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JKA (1986) Binding of HTLV-III/LAV to T +4 T cells by a complex of the 110K viral protein and the T4 molecule. Science 231: 382–385
Meuer SC, Schlossman SF, Reinherz EL (1982) Clonal analysis of human cytotoxic T lymphocytes: T +4 and T +8 effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci USA 79: 4395–4399
Popovic M, Read-Connole E, Gallo RC (1984) T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III. Lancet ii: 1472–1473
Smith DH, Byrn RA, Marsters SA, Gregory T, Groopman JE, Capon DJ (1987) Blocking of HIV-1 infectivity by a soluble, secreted forms of the CD4 antigen. Science 238: 1704–1707
Traunecker A, Lüke W, Karjalainen K (1988) Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature 331: 84–86
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayashi, Y., Ikuta, K., Fujii, N. et al. Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides. Archives of Virology 105, 129–135 (1989). https://doi.org/10.1007/BF01311123
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01311123